SUBSCRIBE
SUBSCRIBE
News   Drug Development

Unique Structure Of Geron Corporation’s Telomerase Inhibitor Drug Promotes Anti-Tumor, Anti-Metastatic Activity In Lung Cancer Cells

February 15, 2007 | 
1 min read
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced the publication of preclinical data that show specific structural elements of GRN163L contribute to its unique anti-tumor and anti-metastatic activity.
Preclinical
MORE ON THIS TOPIC
Electricity saving, ecology awareness or reduce electric cost and expense concept, man pulling electric cord to unplug to save money or for ecology power.
Parkinson’s disease
Biogen, Denali pull plug on Parkinson’s program after mid-stage flop
May 22, 2026
 · 
2 min read
 · 
Tristan Manalac
Crowd silhouettes reach toward a raised trophy beneath a vivid sunset sky, showing shared ambition, victory, teamwork, celebration, and success with open space for text.
Weight loss
Lilly’s triple agonist shows bariatric surgery–like weight loss results
May 21, 2026
 · 
3 min read
 · 
Annalee Armstrong
Fight versus pop art comic red blue background with halftone, rays, hands holding paper. Vector cartoon illustration in retro style. Design for comic book, poster, banner, competition
Leadership
Vaxart seeks shareholder support as battle over stock split brews
May 21, 2026
 · 
2 min read
 · 
Tristan Manalac
Stock market rebound, overcome business down fall and grow up profit or leadership and achievement concept, businessman jump bouncing high on trampoline with green rising up performance arrow graph.
Rare diseases
BioMarin bounces back as Voxzogo performs ‘bigger than expected’ in new indication
May 21, 2026
 · 
2 min read
 · 
Tristan Manalac